Literature DB >> 18802679

Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

I Vareniuk1, I A Pavlov, I G Obrosova.   

Abstract

AIMS/HYPOTHESIS: Evidence for the importance of peroxynitrite, a product of superoxide anion radical reaction with nitric oxide, in peripheral diabetic neuropathy is emerging. The role of specific nitric oxide synthase isoforms in diabetes-associated nitrosative stress and nerve fibre dysfunction and degeneration remains unknown. This study evaluated the contribution of inducible nitric oxide synthase (iNOS) to peroxynitrite injury to peripheral nerve and dorsal root ganglia and development of peripheral diabetic neuropathy.
METHODS: Control mice and mice with iNos (also known as Nos2) gene deficiency (iNos ( -/- )) were made diabetic with streptozotocin, and maintained for 6 weeks. Peroxynitrite injury was assessed by nitrotyrosine and poly(ADP-ribose) accumulation (immunohistochemistry). Thermal algesia was evaluated by paw withdrawal, tail-flick and hot plate tests, mechanical algesia by the Randall-Selitto test, and tactile allodynia by a von Frey filament test.
RESULTS: Diabetic wild-type mice displayed peroxynitrite injury in peripheral nerve and dorsal root ganglion neurons. They also developed motor and sensory nerve conduction velocity deficits, thermal and mechanical hypoalgesia, tactile allodynia and approximately 36% loss of intraepidermal nerve fibres. Diabetic iNos ( -/- ) mice did not display nitrotyrosine and poly(ADP-ribose) accumulation in peripheral nerve, but were not protected from nitrosative stress in dorsal root ganglia. Despite this latter circumstance, diabetic iNos ( -/- ) mice preserved normal nerve conduction velocities. Small-fibre sensory neuropathy was also less severe in diabetic iNos ( -/- ) than in wild-type mice. CONCLUSIONS/
INTERPRETATION: iNOS plays a key role in peroxynitrite injury to peripheral nerve, and functional and structural changes of diabetic neuropathy. Nitrosative stress in axons and Schwann cells, rather than dorsal root ganglion neurons, underlies peripheral nerve dysfunction and degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802679      PMCID: PMC3044437          DOI: 10.1007/s00125-008-1136-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

1.  The use of pholasin as a probe for the determination of plasma total antioxidant capacity.

Authors:  Jaffar Nourooz-Zadeh; Nourooz-Zadeh Jaffar; Dan Ziegler; Ziegler Dan; Christopher Sohr; Sohr Christopher; John D Betteridge; Betteridge D John; Jan Knight; Knight Jan; John Hothersall; Hothersall John
Journal:  Clin Biochem       Date:  2005-12-02       Impact factor: 3.281

2.  Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.

Authors:  Eric C M Ho; Karen S L Lam; Yuk Shan Chen; Johnny C W Yip; Meena Arvindakshan; Shin-Ichiro Yamagishi; Soroku Yagihashi; Peter J Oates; Craig A Ellery; Stephen S M Chung; Sookja K Chung
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

3.  Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.

Authors:  Tiina M Kauppinen; Wai Y Chan; Sang Won Suh; Amanda K Wiggins; Eric J Huang; Raymond A Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

4.  Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

Authors:  Irina G Obrosova; Viktor R Drel; Pal Pacher; Olga Ilnytska; Zhong Q Wang; Martin J Stevens; Mark A Yorek
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

5.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

6.  Impairment of dilator responses of cerebral arterioles during diabetes mellitus: role of inducible NO synthase.

Authors:  Jiro Kitayama; Frank M Faraci; Carol A Gunnett; Donald D Heistad
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

7.  Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes.

Authors:  Prabhakara Reddy Nagareddy; Zhengyuan Xia; John H McNeill; Kathleen M MacLeod
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-08       Impact factor: 4.733

Review 8.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.

Authors:  Prakash Jagtap; Csaba Szabó
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

9.  Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.

Authors:  Subrina Jesmin; Sohel Zaedi; Seiji Maeda; Iwao Yamaguchi; Katsutoshi Goto; Takashi Miyauchi
Journal:  Exp Biol Med (Maywood)       Date:  2006-06

10.  Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.

Authors:  Viktor R Drel; Pal Pacher; Igor Vareniuk; Ivan A Pavlov; Olga Ilnytska; Valeriy V Lyzogubov; Seth R Bell; John T Groves; Irina G Obrosova
Journal:  Int J Mol Med       Date:  2007-12       Impact factor: 4.101

View more
  38 in total

1.  Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.

Authors:  Irina G Obrosova; Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Jerry L Nadler; Robert E Schmidt
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Inactivation of TNF-α ameliorates diabetic neuropathy in mice.

Authors:  Isamu Yamakawa; Hideto Kojima; Tomoya Terashima; Miwako Katagi; Jiro Oi; Hiroshi Urabe; Mitsuru Sanada; Hiromichi Kawai; Lawrence Chan; Hitoshi Yasuda; Hiroshi Maegawa; Hiroshi Kimura
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-02       Impact factor: 4.310

4.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

Review 5.  Vascular dysfunction in the diabetic placenta: causes and consequences.

Authors:  Lopa Leach; Alice Taylor; Flavia Sciota
Journal:  J Anat       Date:  2009-07       Impact factor: 2.610

6.  Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.

Authors:  Liang Zhang; Cuijuan Yu; Francisco E Vasquez; Nadya Galeva; Isaac Onyango; Russell H Swerdlow; Rick T Dobrowsky
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 7.  Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain.

Authors:  Paola Sacerdote; Silvia Franchi; Sarah Moretti; Mara Castelli; Patrizia Procacci; Valerio Magnaghi; Alberto E Panerai
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-16       Impact factor: 4.147

8.  Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivity.

Authors:  Christiane Wetzel; Simone Pifferi; Cristina Picci; Caglar Gök; Diana Hoffmann; Kiran K Bali; André Lampe; Liudmila Lapatsina; Raluca Fleischer; Ewan St John Smith; Valérie Bégay; Mirko Moroni; Luc Estebanez; Johannes Kühnemund; Jan Walcher; Edgar Specker; Martin Neuenschwander; Jens Peter von Kries; Volker Haucke; Rohini Kuner; James F A Poulet; Jan Schmoranzer; Kate Poole; Gary R Lewin
Journal:  Nat Neurosci       Date:  2016-12-12       Impact factor: 24.884

Review 9.  Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain.

Authors:  Abhilasha Ahlawat; Ajay Rana; Nidhi Goyal; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2014-08-06       Impact factor: 4.473

Review 10.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.